Research commissioned by The Brain Tumour Charity leads to new insights on the real lives of adults and children with brain tumours
Bone Cancer Research Trust – new research on the impact of primary bone cancer marks a turning point for the charity
New project announcement:
We are delighted to announce that we have been commissioned by Meningitis Now to conduct what we believe will prove to be a ground-breaking study into the impact of meningitis. As well as seeking to understand more about the effects on individuals and their families we will also be undertaking a detailed evaluation of the charity’s current support services. The evidence generated will inform the charity’s strategic plan and help guide the further development of their support model.
Meningitis Now are dedicated to funding research, raising awareness and providing support to people facing the devastating consequences of meningitis. The charity’s vision is “a future where no-one in the UK loses their lives to meningitis and everyone affected gets the support they need to rebuild their lives.”
‘’We’re excited to be working with the Alterline team to help us to further develop our understanding about the journey and needs of people who have had an experience of meningitis. We’re eager for this to help us develop our new strategic vision and ensure that Meningitis Now is using its resources in the most effective way in order to support people who have encountered meningitis in their lives. We are confident Alterline will deliver research that provokes action and supports our vision: “A future where no-one in the UK loses their lives to meningitis and everyone affected gets the support they need to rebuild their lives.”’
– Sue Davie, CEO of Meningitis Now
New project announcement:
Bone Cancer Research Trust: The next chapter
The Bone Cancer Research Trust has come on an incredible journey since it was founded by a dedicated group of bereaved parents in 2006. To-date they have funded research projects totalling over £2.2m and offered vital support to affected families.
With their 10th anniversary fast approaching, the Trust has commissioned Alterline to help them shape their strategy for the future. At the core of the project will be a quantitative and qualitative research study that captures the impact bone cancer has on those affected. This new, unique evidence base will put people affected by bone cancer at the heart of the Trust’s strategic objectives, and help build a brand personality that aligns with the Charity’s audience.
“We have come such a long way in just 10 years, but we have high ambitions to drive our research and work even further and faster. Bone Cancer Research Trust must be all ears if we’re going to ensure that we can offer the services, information and support that primary bone cancer patients and their families need. I’m confident that our partnership with Alterline will really help us understand people’s experiences and put this at the very core of our work.”
– Julie Harrington, CEO of The Bone Cancer Research Trust